JP5968314B2 - 成分測定装置 - Google Patents
成分測定装置 Download PDFInfo
- Publication number
- JP5968314B2 JP5968314B2 JP2013522932A JP2013522932A JP5968314B2 JP 5968314 B2 JP5968314 B2 JP 5968314B2 JP 2013522932 A JP2013522932 A JP 2013522932A JP 2013522932 A JP2013522932 A JP 2013522932A JP 5968314 B2 JP5968314 B2 JP 5968314B2
- Authority
- JP
- Japan
- Prior art keywords
- abnormality
- measurement
- guidance
- unit
- blood glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000005856 abnormality Effects 0.000 claims description 183
- 238000005259 measurement Methods 0.000 claims description 129
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 86
- 239000008103 glucose Substances 0.000 claims description 86
- 230000004044 response Effects 0.000 claims description 15
- 210000001124 body fluid Anatomy 0.000 claims description 11
- 239000010839 body fluid Substances 0.000 claims description 11
- 230000009471 action Effects 0.000 claims description 6
- 210000003743 erythrocyte Anatomy 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 description 100
- 239000008280 blood Substances 0.000 description 100
- 238000000034 method Methods 0.000 description 20
- 238000012360 testing method Methods 0.000 description 16
- 238000005534 hematocrit Methods 0.000 description 15
- 230000008569 process Effects 0.000 description 15
- 230000002159 abnormal effect Effects 0.000 description 10
- 238000012951 Remeasurement Methods 0.000 description 9
- 230000010485 coping Effects 0.000 description 6
- 238000007726 management method Methods 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- -1 2-hydroxy-3-sulfopropyl Chemical group 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000011328 necessary treatment Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0266—Operational features for monitoring or limiting apparatus function
- A61B2560/0276—Determining malfunction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Human Computer Interaction (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Optics & Photonics (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Description
Claims (5)
- 体液の所定成分を測定する測定部(68)と、
前記測定部(68)による前記所定成分の測定において、異常の有無を検出するとともに、前記異常の種類を判断する異常判断部(85)と、
前記異常判断部(85)で異常が検出されたとき、検出された異常の種類に基づきユーザに異常内容と該異常内容に対応した再測定の要請を含む異常対応第1ガイダンスとを音声形式で伝える異常報知部(88)と、
を有し、
前記異常報知部(88)は、
前記異常判断部(85)で前記体液の所定成分の測定値の異常である測定値異常が検出された後、前記測定部(68)により再度測定が行われたとき、
前記異常判断部(85)が前記測定値異常と同一でない異常を検出した場合に、前記異常対応第1ガイダンスを伝える一方で、
前記異常判断部(85)が前記測定値異常と同一の異常を連続して検出した場合に、前記異常対応第1ガイダンスと異なる再測定の要請以外の対処方法である異常対応第2ガイダンスをユーザに伝えることを特徴とする成分測定装置(10)。 - 請求項1記載の成分測定装置(10)において、
前記異常報知部(88)による前記異常対応第2ガイダンスには、測定値に関連付けられた予測病状データが含まれていることを特徴とする成分測定装置(10)。 - 請求項1記載の成分測定装置(10)において、
前記異常報知部(88)による前記異常対応第2ガイダンスには、測定値に基づく医療ガイダンスが含まれていることを特徴とする成分測定装置(10)。 - 請求項1記載の成分測定装置(10)において、
前記体液の所定成分は、グルコース又は赤血球であることを特徴とする成分測定装置(10)。 - 請求項1記載の成分測定装置(10)において、
前記異常報知部(88)による前記異常対応第2ガイダンスには、前記ユーザが連絡をするべき連絡先が含まれていることを特徴とする成分測定装置(10)。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011143953 | 2011-06-29 | ||
JP2011143953 | 2011-06-29 | ||
PCT/JP2012/066512 WO2013002318A1 (ja) | 2011-06-29 | 2012-06-28 | 成分測定装置及び医療機器 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2013002318A1 JPWO2013002318A1 (ja) | 2015-02-23 |
JP5968314B2 true JP5968314B2 (ja) | 2016-08-10 |
Family
ID=47424204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013522932A Active JP5968314B2 (ja) | 2011-06-29 | 2012-06-28 | 成分測定装置 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5968314B2 (ja) |
WO (1) | WO2013002318A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6200185B2 (ja) * | 2013-04-02 | 2017-09-20 | テルモ株式会社 | 体液成分測定装置 |
JP2015129639A (ja) * | 2013-12-31 | 2015-07-16 | 株式会社ティー・ティー・エム | 分析システム、この分析システムを構成する分析用補助装置、携帯型通信端末、および携帯型通信端末制御用のプログラム |
JP6879752B2 (ja) * | 2017-02-03 | 2021-06-02 | 株式会社日立システムズ | 医療機器監視システム |
CN109030801B (zh) * | 2018-06-02 | 2021-08-20 | 宏葵生物(中国)股份有限公司 | 一种临床样本自动生化分析仪 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4409753B2 (ja) * | 2000-12-04 | 2010-02-03 | テルモ株式会社 | 体液測定装置 |
JP4688365B2 (ja) * | 2001-08-09 | 2011-05-25 | パナソニック株式会社 | 測定装置 |
JP3775263B2 (ja) * | 2001-08-10 | 2006-05-17 | ニプロ株式会社 | 記録媒体およびこの記録媒体を用いた血糖測定システム |
JP2005127802A (ja) * | 2003-10-22 | 2005-05-19 | Arkray Inc | 分析装置 |
-
2012
- 2012-06-28 JP JP2013522932A patent/JP5968314B2/ja active Active
- 2012-06-28 WO PCT/JP2012/066512 patent/WO2013002318A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2013002318A1 (ja) | 2013-01-03 |
JPWO2013002318A1 (ja) | 2015-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190150786A1 (en) | User Interface Enhancements for Physiological Parameter Monitoring Platform Devices | |
US20200329965A1 (en) | Biological information measuring apparatus | |
ES2619595T3 (es) | Dispositivo y método de ensayo de analito para la gestión de la diabetes | |
US8647575B2 (en) | Device for measuring blood component | |
ES2528705T3 (es) | Procedimiento y sistema de prueba de analitos con notificación de tendencias de glucemia alta y baja | |
US20130038453A1 (en) | Blood Sugar Level Measuring Apparatus, Blood Sugar Level Measured Result Display Method and Blood Sugar Level Measured Result Display Control Program | |
JP5968314B2 (ja) | 成分測定装置 | |
KR20140008317A (ko) | 고 분석물 및 저 분석물 경향 통지를 갖는 분석물 검사 방법 및 시스템 | |
TWI412744B (zh) | Measuring device | |
US20150282748A1 (en) | Biological information measurement device | |
JP2003215122A (ja) | 小型検査機器、精度管理チップ及び小型検査機器の精度管理方法 | |
JP2013188240A (ja) | 糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム | |
JP5694830B2 (ja) | 成分測定装置、医療機器及び音声ガイダンス方法 | |
WO2013038826A1 (ja) | 報知システム | |
JP5320111B2 (ja) | 血液成分測定装置 | |
JP5320038B2 (ja) | 血液成分測定装置 | |
TW201401216A (zh) | 根據先前的生理測量之分析給使用者正向加強訊息 | |
JP2013076598A (ja) | 医療機器、エラー情報処理システム及びエラー情報処理プログラム | |
Downie | Practical aspects of capillary blood glucose monitoring: A simple guide for primary care. | |
JP2014052216A (ja) | 測定システム | |
JP6253934B2 (ja) | 成分測定装置、成分測定システム、医療機器及びプログラム | |
JP2012205804A (ja) | 成分測定装置及び医療機器 | |
JP2013009802A (ja) | 成分測定装置及び医療機器 | |
JP2022181355A (ja) | パルスオキシメーター、情報処理方法及びプログラム | |
JP5756318B2 (ja) | 血糖値測定装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150319 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151201 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160126 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160622 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160705 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5968314 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |